These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11760674)

  • 1. [Aerosolized iloprost therapy in an infant with chronic pulmonary hypertension after a neonatal arterial switch operation].
    Lambert V; Serraf A; Durand P; Losay J
    Arch Pediatr; 2001 Nov; 8(11):1218-21. PubMed ID: 11760674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous inhaled iloprost in a neonate with d-transposition of the great arteries and severe pulmonary arterial hypertension.
    Dykes JC; Torres M; Alexander PJ
    Cardiol Young; 2016 Mar; 26(3):571-3. PubMed ID: 26220108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
    Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
    N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery.
    Kirbas A; Yalcin Y; Tanrikulu N; Gürer O; Isik O
    Cardiol J; 2012; 19(4):387-94. PubMed ID: 22825900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
    Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
    Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
    Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.
    Olschewski H; Rohde B; Behr J; Ewert R; Gessler T; Ghofrani HA; Schmehl T
    Chest; 2003 Oct; 124(4):1294-304. PubMed ID: 14555558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
    Schenk P; Petkov V; Madl C; Kramer L; Kneussl M; Ziesche R; Lang I
    Chest; 2001 Jan; 119(1):296-300. PubMed ID: 11157622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.
    Hallioglu O; Dilber E; Celiker A
    Am J Cardiol; 2003 Oct; 92(8):1007-9. PubMed ID: 14556887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newborn.
    Avila-Alvarez A; Bravo-Laguna MC; Bronte LD; Del Cerro MJ
    Pediatr Cardiol; 2013; 34(8):2027-9. PubMed ID: 23143352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H; Simonneau G; Galiè N; Higenbottam T; Naeije R; Rubin LJ; Nikkho S; Speich R; Hoeper MM; Behr J; Winkler J; Sitbon O; Popov W; Ghofrani HA; Manes A; Kiely DG; Ewert R; Meyer A; Corris PA; Delcroix M; Gomez-Sanchez M; Siedentop H; Seeger W;
    N Engl J Med; 2002 Aug; 347(5):322-9. PubMed ID: 12151469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.